Awakn Life Sciences Corp.: Awakn Life Sciences Announces the Findings from the Phase II A/B Study Are to Be Published in the American Journal of Psychiatry

World's First Controlled Study to Investigate Ketamine-Assisted Psychotherapy
Toronto, Ontario--(Newsfile Corp. - November 4, 2021) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn')

Related Keywords

United States ,Canada ,United Kingdom ,Toronto ,Ontario ,Exeter ,Devon ,America ,American ,Anne Donohoe ,Celia Morgan ,Anthony Tennyson ,Paul Jarman Anna Ramsey ,Linkedin Facebook ,Valter Pinto Tim Regan ,Awakn Life Sciences ,Awakn Life Sciences Corp ,Morgan ,Newsfile Corp ,Strategic Communications ,University Of Exeter Uo ,University Of Exeter ,First Controlled Study ,Investigate Ketamine Assisted ,Life Sciences ,Alcoholic Relapse ,American Journal ,Qualitative Study ,Patient Experiences ,Executive Officer ,United States Securities Act ,Tim Regan ,Awakn ,Life ,Ciences ,Orp ,Nnounces ,Findings ,Rom ,Hase ,Study ,Published ,Journal ,Sychiatry ,